In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, BioVie Inc’s stock clocked out at $1.48, down -9.20% from its previous closing price of $1.63. In other words, the price has decreased by -$9.20 from its previous closing price. On the day, 0.6 million shares were traded.
Ratios:
To gain a deeper understanding of BIVI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.94 and its Current Ratio is at 16.94. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 22, 2022, initiated with a Overweight rating and assigned the stock a target price of $7.
On January 15, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $47.
Stock Price History:
Over the past 52 weeks, BIVI has reached a high of $33.10, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -28.25%, while the 200-Day Moving Average is calculated to be -50.88%.
Shares Statistics:
A total of 18.45M shares are outstanding, with a floating share count of 16.04M. Insiders hold about 13.06% of the company’s shares, while institutions hold 4.10% stake in the company.
